Table 1.
Patient characteristics.
| Group | Male /Female |
Age 1 | Onset Age 1 | PASI Before Treatment 1 |
PASI Current 1 |
|---|---|---|---|---|---|
| No-therapy group (n = 7) |
5/2 | 51.6 ± 21.4 (16–82) |
35.0 ± 19.2 (12–61) |
N/A | 5.8 ± 3.6 (0.4–11.3) |
| TNFi group (n = 5) |
2/3 | 50.2 ± 16.2 (33–82) |
33.6 ± 12.6 (21–57) |
10.2 ± 5.7 (0.4–18.2) |
1.8 ± 2.1 (0–5.6) |
| IL-17i group (n = 7) |
3/4 | 56.9 ± 22.8 (16–83) |
38.1 ± 20.3 (12–65) |
27.2 ± 16.6 (4.3–59.1) |
0.2 ± 0.5 (0–1.5) |
1 average ± S.D (range), PASI: psoriasis area and severity index, N/A: not applicable